Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Up 4.6% – Time to Buy?

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS)’s stock price rose 4.6% on Monday . The company traded as high as $15.84 and last traded at $15.72. Approximately 189,995 shares traded hands during trading, a decline of 8% from the average daily volume of 206,986 shares. The stock had previously closed at $15.03.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. The Goldman Sachs Group cut their target price on shares of Kestra Medical Technologies from $24.00 to $23.00 and set a “neutral” rating on the stock in a report on Wednesday, April 16th. Wells Fargo & Company started coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued an “overweight” rating and a $28.00 price target on the stock. Bank of America started coverage on shares of Kestra Medical Technologies in a research note on Monday, March 31st. They set a “buy” rating and a $30.00 price objective for the company. Piper Sandler assumed coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They issued an “overweight” rating and a $27.00 target price on the stock. Finally, Stifel Nicolaus started coverage on Kestra Medical Technologies in a research report on Monday, March 31st. They set a “buy” rating and a $28.00 price target for the company. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Kestra Medical Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $27.50.

Kestra Medical Technologies Trading Up 2.9%

The firm’s 50-day moving average price is $21.96.

Kestra Medical Technologies (NASDAQ:KMTS) last posted its quarterly earnings data on Monday, April 14th. The company reported ($1.25) earnings per share for the quarter, missing the consensus estimate of ($0.64) by ($0.61). During the same quarter last year, the company earned ($1.18) earnings per share.

Hedge Funds Weigh In On Kestra Medical Technologies

A number of institutional investors have recently added to or reduced their stakes in the company. Quarry LP purchased a new stake in shares of Kestra Medical Technologies in the 1st quarter worth about $33,000. Virtu Financial LLC purchased a new stake in Kestra Medical Technologies in the first quarter worth about $210,000. Armistice Capital LLC bought a new position in shares of Kestra Medical Technologies during the first quarter valued at approximately $312,000. Zimmer Partners LP purchased a new position in shares of Kestra Medical Technologies during the first quarter valued at approximately $374,000. Finally, Russell Investments Group Ltd. bought a new stake in shares of Kestra Medical Technologies in the 1st quarter worth approximately $457,000.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.